e-learning
resources
Vienna 2012
Monday, 03.09.2012
Chest wall, thoracic trauma and complications in thoracic surgery
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Karnofsky score, pH and degree of pleural involvement as prognostic factors for survival in patients with malignant pleural effusions
A. Yankulov, A. Chapkanov, K. Mourdjev, A. Uchikov, D. Petrov (Plovdiv, Sofia, Bulgaria)
Source:
Annual Congress 2012 - Chest wall, thoracic trauma and complications in thoracic surgery
Session:
Chest wall, thoracic trauma and complications in thoracic surgery
Session type:
Thematic Poster Session
Number:
2431
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Yankulov, A. Chapkanov, K. Mourdjev, A. Uchikov, D. Petrov (Plovdiv, Sofia, Bulgaria). Karnofsky score, pH and degree of pleural involvement as prognostic factors for survival in patients with malignant pleural effusions. Eur Respir J 2012; 40: Suppl. 56, 2431
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
The physiology of breathlessness
Related content which might interest you:
The survival prediction of malignant pleural effusion and the validation of LENT prognosis score in Thai patients.
Source: International Congress 2017 – Pleural and mediastinal malignancies
Year: 2017
Histology, performance status and lymphopenia are factors of survival in patients undergoing thoracoscopy for malignant pleural effusion
Source: Annual Congress 2009 - Trends in bronchoscopy
Year: 2009
Prognostic significance of pleural tumour burden in patients with malignant pleural effusions
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010
Prognostic value of treatment outcomes patients with malignant pleural mesothelioma
Source: Annual Congress 2010 - Current issues in malignant pleural diseases
Year: 2010
Clinical and biological prognostic factors in malignant pleural effusion (MPE) secondary to breast cancer
Source: Annual Congress 2005 - What's new in the pleura
Year: 2005
Predictors of survival in patients with recurrent malignant pleural effusion
Source: Annual Congress 2008 - Diagnostic and therapeutic approaches in pleural diseases
Year: 2008
The presence of human mammaglobin transcripts in the pleural effusion is not predictive of survival in patients with malignant mesothelioma
Source: Annual Congress 2008 - Biology in thoracic tumours
Year: 2008
Pre-therapeutic staging and prognostic factors in malignant pleural mesothelioma patients
Source: Annual Congress 2009 - Malignant pleural mesothelioma guidelines
Year: 2009
Is comorbidity a good prognostic factor for malignant pleural mesothelioma?
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008
Prognostic significance of neutrophil predominance in pleural fluid in patients with malignant effusion
Source: Annual Congress 2010 - Current issues in malignant pleural diseases
Year: 2010
Prognostic significance of pretreatment clinical and laboratory characteristics in patients with diffuse malignant pleural mesothelioma
Source: Eur Respir J 2006; 28: Suppl. 50, 784s
Year: 2006
LENT Score: predicting the survival of malignant pleural effusion–a prospective study of three years
Source: International Congress 2019 – Biology and prognosis of lung cancer
Year: 2019
Diagnostic value and prognostic significance of pleural C-reactive protein in lung cancer with malignant pleural effusions
Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology
Year: 2012
Therapeutic outcome and prognostic factors in patients with pleural mesothelioma
Source: Eur Respir J 2005; 26: Suppl. 49, 73s
Year: 2005
Is pleural VEGF a useful parameter?
Source: Annual Congress 2007 - Pleural malignancy
Year: 2007
Prognostic factors in patients with malignant pleural effusion undergoing thoracoscopy
Source: Annual Congress 2011 - From outside to inside: access to the pleura
Year: 2011
Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients
Source: Eur Respir J 2011; 38: 1425-1430
Year: 2011
Prognostic role of inflammatory cells in blood, pleural fluid and tumour samples, in patients with malignant pleural mesothelioma (MPM)
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017
The value of IL6 in differentiation between malignant and non malignant pleural effusion
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009
Malignant pleural mesothelioma (MPM): clinical presentation, complications and survival
Source: Eur Respir J 2002; 20: Suppl. 38, 272s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept